{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:01:12Z","timestamp":1787896872116,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.euf.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T09:40:28Z","timestamp":1462009228000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"2","author":[{"given":"Giacomo","family":"Novara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-M.","family":"C\u00f3zar-Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Descazeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2016.04.002_bib0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0190","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2010.05.045","article-title":"A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines","volume":"58","author":"Cornu","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2013.02.026","article-title":"Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: a comprehensive population study","volume":"64","author":"Lukacs","year":"2013","journal-title":"Eur Uro"},{"key":"10.1016\/j.euf.2016.04.002_bib0205","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.eursup.2009.11.005","article-title":"Serenoa repens: the scientific basis for the treatment of benign prostatic hyperplasia","volume":"8","author":"Habib","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.euf.2016.04.002_bib0210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11934-014-0463-9","article-title":"The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy","volume":"15","author":"Ficarra","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2016.04.002_bib0215","first-page":"CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Tacklind","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2016.04.002_bib0220","unstructured":"Guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products\/traditional herbal medicinal products. European Medicines Agency Web site. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/09\/WC500113210.pdf"},{"key":"10.1016\/j.euf.2016.04.002_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.pcan.4500746","article-title":"Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract","volume":"7","author":"Habib","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2016.04.002_bib0230","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000161128","article-title":"Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells","volume":"82","author":"Scaglione","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.euf.2016.04.002_bib0235","first-page":"569","article-title":"Comparison of the potency of 10 different brands of Serenoa repens extracts","volume":"16","author":"Scaglione","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.euf.2016.04.002_bib0240","series-title":"Randomised controlled trials","author":"Jadad","year":"1998"},{"key":"10.1016\/j.euf.2016.04.002_bib0245","series-title":"Publication bias in meta-analysis: prevention, assessment and adjustment","author":"Rothstein","year":"2005"},{"key":"10.1016\/j.euf.2016.04.002_bib0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euf.2016.04.002_bib0255","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/039156038305000615","article-title":"Comparison of Serenoa repens extract and placebo in controlled clinical trial in patients with prostatic adenomatosis","volume":"50","author":"Boccafoschi","year":"1983","journal-title":"Urologia"},{"key":"10.1016\/j.euf.2016.04.002_bib0260","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/039156038305000517","article-title":"Risultati clinici su un nuovo farmaco nella terapia dell\u2019ipertofia della prostata (Permixon)","volume":"50","author":"Emili","year":"1983","journal-title":"Urologia"},{"key":"10.1016\/j.euf.2016.04.002_bib0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/039156038305000414","article-title":"Terapia medica dell\u2019adenoma prostatico: confronto della efficacia dell\u2019estratto di Serenoa Repens (Permixon\u00ae) versus l\u2019estratto di Pigeum Africanum e placebo. Valutazione in doppio cieco","volume":"50","author":"Mandressi","year":"1983","journal-title":"Urologia"},{"key":"10.1016\/j.euf.2016.04.002_bib0270","first-page":"15","article-title":"Permixon versus placebo; resultats d\u2019une \u00e9tude multicentrique","volume":"4","author":"Cukier","year":"1985","journal-title":"C R Ther Pharmacol Clin"},{"key":"10.1016\/j.euf.2016.04.002_bib0275","first-page":"87","article-title":"Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo [in Italian]","volume":"37","author":"Tasca","year":"1985","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.euf.2016.04.002_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.1986.tb05424.x","article-title":"The value of Permixon in benign prostatic hypertrophy","volume":"58","author":"Reece Smith","year":"1986","journal-title":"Br J Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00044011-199509050-00007","article-title":"Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after the exclusion of placebo responders","volume":"5","author":"Descotes","year":"1995","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.euf.2016.04.002_bib0290","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0302-2838(02)00066-0","article-title":"Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"41","author":"Debruyne","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0295","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/pros.23059","article-title":"Effects of hexanic extract of Serenoa repens (Permixon\u00ae 160mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"75","author":"Latil","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.04.002_bib0300","first-page":"395","article-title":"Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial [in French]","volume":"12","author":"Gl\u00e9main","year":"2002","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000366521","article-title":"Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study","volume":"94","author":"Ryu","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2016.04.002_bib0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","article-title":"Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients","volume":"29","author":"Carraro","year":"1996","journal-title":"Prostate"},{"issue":"Suppl 4","key":"10.1016\/j.euf.2016.04.002_bib0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1464-410X.2005.05486.x","article-title":"Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function","volume":"95","author":"Lowe","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.04.002_bib0320","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0325","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.04.002_bib0330","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.2011.1364","article-title":"Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial","volume":"306","author":"Barry","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2016.04.002_bib0335","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa053085","article-title":"Saw palmetto for benign prostatic hyperplasia","volume":"354","author":"Bent","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2016.04.002_bib0340","first-page":"CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Wilt","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2016.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1464-410X.2012.11172.x","article-title":"Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review","volume":"109","author":"MacDonald","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.04.002_bib0350","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2125.1984.tb02491.x","article-title":"A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia","volume":"18","author":"Champault","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.euf.2016.04.002_bib0355","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1464-410X.2003.04735.x","article-title":"Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia","volume":"93","author":"Boyle","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.04.002_bib0360","unstructured":"European Union herbal monograph on Serenoa repens (W. Bartram) Small, fructus. 24 November 2015, EMA\/HMPC\/280079\/2013 [p. 1-5]. European Medicines Agency Web site. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Herbal_-_Herbal_monograph\/2016\/01\/WC500199750.pdf"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916300219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916300219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:46:08Z","timestamp":1762497968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456916300219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2405456916300219"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2016.04.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}